Worth reading
53Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Definitive
How definitive the wording is.Announced details
flier Summary Book Club
Applicable field (uses covered by this announcement)
Revitalizing internal communication and addressing organizational challenges
Relationship between the counterparty and the company
Flier Inc.323A
Relationship with the Company
Customer that adopted our corporate book club service
CounterpartyTaiho Pharmaceutical Co., Ltd.
Impact on Business Performance
The company stated that it would work to enhance awareness of the service and increase corporate value, but the specific impact on earnings is Not disclosed
The company does not address Contract Value / Offering price.
Source (materials cited by the company)
Toyo Keizai Online
| Item | Details |
|---|---|
| Names of Products / Services Covered | flier Summary Book Club |
| Counterparty | Taiho Pharmaceutical Co., Ltd. |
| Relationship with the Company | Customer that adopted our corporate book club service |
| Applicable area | Revitalizing internal communication and addressing organizational challenges |
| Impact on Business Performance | The company stated that it would work to enhance awareness of the service and increase corporate value, but the specific impact on earnings is Not disclosed |
| Source | Toyo Keizai Online |
Items this document does not state (12)
Counterparty overviewContract ValueOffering priceContract DateLaunch dateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage history
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To showcase the background and effects of Taiho Pharmaceutical Co., Ltd.’s introduction of the service to revitalize internal communication as an example of how our service helps companies address organizational challenges.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.